Skip to main content

Table 3 Factors associated with glycemic control

From: A comparative study of the quality of care and glycemic control among ambulatory type 2 diabetes mellitus clients, at a Tertiary Referral Hospital and a Regional Hospital in Central Kenya

Variable Glycemic control OR (95% CI) P value
Good (HbA1c<7) Poor (HbA1c≥7)
Age 59.6 (12.4) 57.4 (12.3) 0.351
Gender
 Female 22 (64.7) 111 (66.9) 0.9 (0.4–2.0) 0.808
 Male 12 (35.3) 55 (33.1) 1.0  
Highest level of education
 None 5 (14.7) 29 (17.5) 1.0  
 Primary 14 (41.2) 68 (41.0) 1.2 (0.4–3.6) 0.754
 Secondary 10 (29.4) 51 (30.7) 1.1 (0.4–3.7) 0.829
 Tertiary 5 (14.7) 18 (10.8) 1.6 (0.4–6.4) 0.493
Duration of diabetes
 ≤10 years 26 (76.5) 109 (65.7) 1.7 (0.7–4.0) 0.220
 More than 10 years 8 (23.5) 57 (34.3) 1.0  
Frequency of self monitoring
 Daily/weekly 3 (8.8) 35 (21.1) 1.0  
 Monthly 11 (32.4) 48 (28.9) 2.7 (0.7–10.3) 0.141
 Don’t test 20 (58.8) 83 (50.0) 2.8 (0.8–10.1) 0.100
Frequency of clinic visits
 Weekly/fortnightly 1 (2.9) 5 (3.0) 1.0  
 Monthly 22 (64.7) 113 (68.1) 1.0 (0.1–8.7) 1.000
 6 months 11 (32.4) 48 (28.9) 1.1 (0.1–10.8) 1.000
Accessibility
 Easy 31 (91.2) 154 (92.8) 0.8 (0.2–3.0) 0.724
 Difficult 3 (8.8) 12 (7.2) 1.0  
Affordability
 Affordable 19 (55.9) 104 (62.7) 0.8 (0.4–1.6) 0.460
 Not affordable 15 (44.1) 62 (37.3) 1.0  
Satisfaction
 Satisfied 33 (97.1) 165 (99.4) 0.2 (0.0–3.3) 0.312
 Not satisfied 1 (2.9) 1 (0.6) 1.0  
Compliance
 High adherence 24 (70.6) 77 (46.4) 2.8 (1.2–6.2) 0.010
 Intermediate/low adherence 10 (29.4) 89 (53.6) 1.0  
Diabetic drugs availability
 Yes all the drugs 31 (79.5 %) 8 (20.5 %) 1.0 0.637
 Yes some drugs are available 120 (82.8 %) 25 (17.2 %) 1.2 (0.5–3.0) 0.221
 No 15 (93.8 %) 1 (6.3 %) 3.9 (0.4–33.8)